Conventional medical therapy in heart failure patients eligible for the PARADIGM-HF, DAPA-HF, and SHIFT trials.
Shoji S, Kohsaka S, Shiraishi Y, Kohno T, Sawano M, Ikemura N, Niimi N, Nagatomo Y, Tanaka TD, Takei M, Ono T, Sakamoto M, Nakano S, Nakamura I, Inoue S, Fukuda K, Yoshikawa T.
Shoji S, et al. Among authors: tanaka td.
Int J Cardiol. 2022 Jul 15;359:76-83. doi: 10.1016/j.ijcard.2022.04.020. Epub 2022 Apr 11.
Int J Cardiol. 2022.
PMID: 35421518